Nexcella

Los Angeles, United States

Nexcella Utilize cell therapies to create safe and effective medicines for oncology and other conditions, improving patient outcomes.

$8.0M raised

Jul 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nexcella raised?

Nexcella has raised $8.0M in total funding. The most recent round was Grant. The last funding was announced in July 2024.

Who are Nexcella's investors?

Nexcella's investors include California Institute for Regenerative Medicine.

Where is Nexcella headquartered?

Nexcella is headquartered in Los Angeles, United States.

What does Nexcella do?

Nexcella Utilize cell therapies to create safe and effective medicines for oncology and other conditions, improving patient outcomes.

What stage is Nexcella at?

Nexcella is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 25, 2024.

MLA

"Nexcella — Funding & Investors." VCBacked, July 25, 2024, https://www.vcbacked.co/company/nexcella. Accessed July 2, 2026.

APA

VCBacked. (2024). Nexcella — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nexcella

Wikipedia (cite web)

{{cite web |title=Nexcella — Funding & Investors |url=https://www.vcbacked.co/company/nexcella |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 25, 2024.